“We anticipate that these expert multisocietal consensus recommendations on multimodality imaging in cardiac amyloidosis will standardize the diagnosis and improve the management of this highly morbid and underdiagnosed disease," wrote authors of the new guidelines published in the Journal of Nuclear Cardiology.

Multiple nuclear medicine and cardiology groups are working to oppose potential cuts to myocardial PET scans that were made possible by the CMS 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, according to a joint statement.

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

When CMS released the 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, it included revisions that could lead to technical component payment reductions of up to 80% for certain services related to myocardial PET scans.

A study funded by the Mayo Clinic and published in Circulation: Arrhythmia and Electrophysiology this week suggests AI could be successfully applied to ECG data to measure a person’s overall health status.

Greater left ventricular mass identified on MRI is a better predictor of coronary artery disease-related death and heart failure compared to coronary artery calcium (CAC) scoring, reported authors of a multi-center study published in Radiology.

A study published in JAMA Network Open August 11 suggests that, despite the growing use of imaging modalities like computed tomography and MRI, echocardiography remains the most popular method for imaging patients with heart failure.

Resting echocardiography stands head above shoulders as the most used imaging modality for patients with heart failure in Canada, according to a 14-year analysis published in JAMA Network Open.